Works about TELOMERASE reverse transcriptase


Results: 962
    1
    2

    Pathogenic effects of telomerase reverse transcriptase (TERT) promoter mutations in nonalcoholic steatohepatitis (NASH) related hepatocellular carcinoma (HCC) and its potentials as a diagnostic biomarker.

    Published in:
    Egyptian Journal of Medical Human Genetics, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s43042-025-00738-z
    By:
    • Umar Liman, Usman;
    • Hawage, Asanka Sudeshini;
    • De Silva, Sumadee;
    • Samarasinghe, Saumya Madushani;
    • Tennekoon, Kamani Hemamala;
    • Siriwardana, Rohan Chaminda;
    • Niriella, Madunil Anuk
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    NEW TERT VARIANT IN A FAMILY WITH APLASTIC ANEMIA.

    Published in:
    Genetics & Applications, 2024, p. 42
    By:
    • Marijana, Virijević;
    • Irena, Marjanovic;
    • Marina, Andjelkovic;
    • Teodora, Karan-Djurasevic;
    • Branka, Zukic;
    • Jovana, Komazec;
    • Ivana, Grubisa;
    • Biljana, Stankovic;
    • Andrija, Bogdanović;
    • Sonja, Pavlovic
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer.

    Published in:
    Oncology Letters, 2021, v. 22, n. 2, p. N.PAG, doi. 10.3892/ol.2021.12851
    By:
    • Crezee, Thomas;
    • Tesselaar, Marika H.;
    • Jaeger, Martin;
    • Rabold, Katrin;
    • Corver, Willem E.;
    • Morreau, Hans;
    • Van Engen-Van Grunsven, Adriana C.H.;
    • Smit, Jan W.A.;
    • Netea-Maier, Romana T.;
    • Plantinga, Theo S.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Telomeres and telomerase in oncogenesis.

    Published in:
    Oncology Letters, 2020, v. 20, n. 2, p. 1015, doi. 10.3892/ol.2020.11659
    By:
    • Trybek, Tomasz;
    • Kowalik, Artur;
    • Góźdź, Stanisław;
    • Kowalska, Aldona
    Publication type:
    Article
    40
    41
    42
    43
    44

    Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.

    Published in:
    Oncology Letters, 2018, v. 15, n. 6, p. 9174, doi. 10.3892/ol.2018.8470
    By:
    • Romei, Cristina;
    • Tacito, Alessia;
    • Molinaro, Eleonora;
    • Piaggi, Paolo;
    • Cappagli, Virginia;
    • Pieruzzi, Letizia;
    • Matrone, Antonio;
    • Viola, David;
    • Agate, Laura;
    • Torregrossa, Liborio;
    • Ugolini, Clara;
    • Basolo, Fulvio;
    • De Napoli, Luigi;
    • Curcio, Michele;
    • Ciampi, Raffaele;
    • Materazzi, Gabriele;
    • Vitti, Paolo;
    • Elisei, Rossella
    Publication type:
    Article
    45

    High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.

    Published in:
    Oncology Letters, 2018, v. 15, n. 3, p. 3061, doi. 10.3892/ol.2017.7671
    By:
    • Bao, Halin;
    • Bai, Tuya;
    • Takata, Koji;
    • Yokobori, Takehiko;
    • Ohnaga, Takashi;
    • Hisada, Takeshi;
    • MaENo, Toshitaka;
    • Bao, Pinjie;
    • Yoshida, Tomonori;
    • Kumakura, Yuji;
    • Honjo, Hiroaki;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Fukuchi, Minoru;
    • Altan, Bolag;
    • Handa, Tadashi;
    • Ide, MunENori;
    • Miyazaki, Tatsuya;
    • Ogata, Kyoichi;
    • Oyama, Tetsunari
    Publication type:
    Article
    46
    47
    48
    49
    50